vimarsana.com

Page 394 - புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Silver Spruce Provides Mining Registry Update on Pino de Plata Ag Project, Chihuahua, Mexico

Press release content from Accesswire. The AP news staff was not involved in its creation. Silver Spruce Provides Mining Registry Update on Pino de Plata Ag Project, Chihuahua, Mexico December 24, 2020 GMT BEDFORD, NS / ACCESSWIRE / December 16, 2020 / Silver Spruce Resources Inc. (TSXV:SSE)(Frankfort:S6Q1) (the Company ) announced today a private placement of 8,333,334 flow-through units at a price of $0.06 per flow-through unit for gross proceeds . BEDFORD, NS / ACCESSWIRE / December 16, 2020 / Silver Spruce Resources Inc. (TSXV:SSE)(Frankfort:S6Q1) (the Company ) announced today a private placement of 8,333,334 flow-through units at a price of $0.06 per flow-through unit for gross proceeds . BEDFORD, NS / ACCESSWIRE / December 24, 2020 / Silver Spruce Resources, Inc. (“Silver Spruce” or the “Company”) (TSXV:SSE) is very pleased to provide the following update on the Pino de Plata Project announcing that its Option Agreement (“Agreement”) with the concession titl

Allied Moves to Become Leader in Psilocybin Space with Intent to Acquire of Pacific Sun Fungi

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Allied Moves to Become Leader in Psilocybin Space with Intent to Acquire of Pacific Sun Fungi Allied Corp.December 24, 2020 GMT KELOWNA, British Columbia, Dec. 24, 2020 (GLOBE NEWSWIRE) Allied Corp. (“Allied”) (OTCQB: ALID) – an international medical cannabis company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to announce the signing of a letter of intent to acquire the psilocybin company Pacific Sun Fungi (“Pacific Sun”). This further expands upon Allied’s press release of October 20, 2020 communicating the submission of the provisional patent for Allied’s functional mushroom formulation targeting major depression and anxiety.

Disposable Cups Market Report: Covid-19 Effect, Market Scope and Insights | Georgia-Pacific LLC, Dart Container Corporation

Press release content from Wired Release. The AP news staff was not involved in its creation. Disposable Cups Market Report: Covid-19 Effect, Market Scope and Insights | Georgia-Pacific LLC, Dart Container Corporation December 24, 2020 GMT Pune, Maharashtra, India, December 24 2020 (Wiredrelease) MarketResearch.Biz :The Disposable Cups 2020 market research report from MarketResearch.Biz provides a brief overview of the geographic scope, market size, extensive insights, extensive analysis, and market revenue estimates up to 2029. The report is made up of so many key things that are relevant in order to provide a correct overview of the industry. The Disposable Cupsmarket is divided into segments and dividers in a global framework. The study provides the most up-to-date production information used by Disposable Cupsfield surveys. To provide a deeper understanding of the user, all information points and data used in the Disposable Cupsmarket report are provided in the form of bar ch

Urovant Sciences Announces U S FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)

Press release content from Business Wire. The AP news staff was not involved in its creation. Urovant Sciences Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB) December 23, 2020 GMT IRVINE, Calif. & BASEL, Switzerland (BUSINESS WIRE) Dec 23, 2020 Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for once-daily 75 mg GEMTESA® (vibegron), a beta-3 adrenergic receptor (β3) agonist, for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence (UUI), urgency, and urinary frequency in adults. This approval marks the first new oral branded OAB medication approved by the FDA since 2012, and it is the first product approval for Urovant Sciences.

Rapid Advancements In Power Amplifier Market, Is Expected to Grasp USD 30,371 3 Mn By 2030 at 5 9% CAGR -Market Biz

Press release content from Wired Release. The AP news staff was not involved in its creation. Rapid Advancements In Power Amplifier Market, Is Expected to Grasp USD 30,371.3 Mn By 2030 at 5.9% CAGR -Market.Biz December 24, 2020 GMT Pune, Maharashtra, December 24 2020 (Wiredrelease) Market.Biz :Market.Biz offers accurate information and a holistic view of the Power Amplifier Market With COVID-19 Statistical Assessment. Further, It consists of a detailed investigation of vend stats, Business opportunities, and industry-specific perspective so as to enable Power Amplifier Industry shareholders to take a vital decision on their future projects. The Power Amplifier report summarizes the upcoming market trends based on production technology, developmental plans, and technological advancement. The report considers all the major aspects pertaining to Power Amplifier business stability, basics concepts followed to understand the business tactics. Additionally, the report delivers a precis

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.